We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

124 hedge funds and large institutions have $416M invested in Spectrum Pharmaceuticals Inc in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 42 increasing their positions, 46 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

425% more call options, than puts

Call options by funds: $677K | Put options by funds: $129K

18% more capital invested

Capital invested by funds: $353M → $416M (+$62.8M)

9% less repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 46

3% less funds holding

Funds holding: 128124 (-4)

25% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 16

Holders
124
Holders Change
-4
Holders Change %
-3.13%
% of All Funds
3.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
42
Reduced
46
Closed
16
Calls
$677K
Puts
$129K
Net Calls
+$548K
Net Calls Change
+$222K

SPPI Hedge Fund Activity: Q2 2017 in Review

124 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q2 2017, worth a combined $416M — up 18% from $353M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of SPPI and 12 opened new positions — a net loss of 4 holders — while 46 trimmed existing stakes and 42 added.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $13.2M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $4.31M sold.

  • 124 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q2 2017, down from 128 in Q1 2017.
  • Funds reported $416M of Spectrum Pharmaceuticals Inc stock for Q2 2017, up 18% quarter-over-quarter.
  • 12 funds opened new Spectrum Pharmaceuticals Inc positions in Q2 2017 and 16 closed out, a net change of -4 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q2 2017 was Consonance Capital Management, an estimated $13.2M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q2 2017 was Acadian Asset Management, an estimated $4.31M sold.

Based on aggregated 13F filings for Q2 2017.